首页> 外国专利> SYSTEM OR METHOD FOR ENGAGING PATIENTS, COORDINATING CARE, PHARMACOVIGILANCE, ANALYSIS OR MAXIMIZING SAFETY OR CLINICAL OUTCOMES

SYSTEM OR METHOD FOR ENGAGING PATIENTS, COORDINATING CARE, PHARMACOVIGILANCE, ANALYSIS OR MAXIMIZING SAFETY OR CLINICAL OUTCOMES

机译:参与患者,协调护理,药物治疗,分析或最大程度地提高安全性或临床结果的系统或方法

摘要

The invention provides a Platform or Application, via numerous systems and methods, involving software, code, pseudo-code, databases, schemas, algorithms, inference engines, and user interfaces including but not limited to Complex Event Processing (CEP) artificial intelligence, for pharmacotherapy management and evaluation (specifically managing medication therapy regimens), maximizing patient safety and Medication efficacy, coordinating care among disparate Providers, improving clinical outcomes, regulatory reporting, and research, learning, or knowledge discovery via analysis. More specifically, the invention is comprised of a mobile and digital health intervention platform with various modules addressing health challenges related to medication non-adherence behaviors, predicting and preventing medication non-adherence, identifying and overcoming reasons for non-adherence, identifying risks or preventing adverse drug interactions (ADR) (e.g., between medications (polypharmacy), environments, age or consumables), and/or adverse events (AE), automatically tracking and reporting adverse events (AE), coordinating care amongst a diversified healthcare treatment team (medical concordance), or conducting Analysis, research, knowledge discovery or learning regarding the data (events). Users include Patients, caregivers, health care Providers, Pharmaceutical Manufacturers, Insurance Carriers, National Health Services, Payers, or other interested parties.
机译:本发明通过许多系统和方法提供平台或应用程序,用于软件,代码,伪代码,数据库,模式,算法,推理引擎和用户界面,包括但不限于复杂事件处理(CEP)人工智能,用于药物治疗管理和评估(特别是管理药物治疗方案),最大限度地提高患者安全性和药物疗效,在不同医疗机构之间协调护理,改善临床结果,监管报告以及通过分析进行研究,学习或知识发现。更具体地,本发明包括具有各种模块的移动和数字健康干预平台,所述模块解决与药物非依从行为有关的健康挑战,预测和预防药物非依从性,识别和克服非依从性的原因,识别风险或预防不良药物相互作用(ADR)(例如,药物(多药店之间),环境,年龄或消耗品之间)和/或不良事件(AE),自动跟踪和报告不良事件(AE),在多元化的医疗保健治疗团队之间协调护理(医疗一致性),或进行有关数据(事件)的分析,研究,知识发现或学习。用户包括患者,护理人员,医疗保健提供者,药品制造商,保险公司,国民健康服务机构,付款人或其他有关方。

著录项

  • 公开/公告号US2018308569A1

    专利类型

  • 公开/公告日2018-10-25

    原文格式PDF

  • 申请/专利权人 S ERIC LUELLEN;

    申请/专利号US201715496950

  • 发明设计人 S ERIC LUELLEN;

    申请日2017-04-25

  • 分类号G16H20/10;G16H10/60;G16H50/20;

  • 国家 US

  • 入库时间 2022-08-21 12:59:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号